|
|
||
|---|---|---|
| UniProt ID |
Q7Z7D3 |
|
| Entry Name |
VTCN1_HUMAN |
|
| Protein Name |
V-set domain-containing T-cell activation inhibitor 1 |
|
| Primary Gene Name |
VTCN1 |
|
| Organism |
Homo sapiens (Human) |
|
| Molecular Function | ||
| Membrane Location |
Cell membrane |
|
|
|
|---|
| Substrate Name | T-cell activation inhibitor-1 (VTCN1,B7-H4) | |
| Cell Type | ||
| Substrate Description | negatively regulates T-cell-mediated immune response by inhibiting T-cell activation, proliferation, cytokine production and development of cytotoxicity. | |
| Substrate Function Category | Immune and Inflammation | |
| Substrate Function Subtype | ||
| Sheddase | metalloproteinase nardilysin | |
| Shedding-related Disease | ligand | |
| Short Summary of Papers | membrane-tethered VTCN1 undergoes proteolytic cleavage mediated by the metalloproteinase nardilysin, the blood sVTCN1 levels may be of potential use as type 1 diabetes biomarker. | |
| Cleavage Information | NONE | |
| PMID | 24848066 |
|
|
|---|
|
|
||
|---|---|---|
|
|
Start | End |
|
|
25 | 259 |
|
|
260 | 280 |
|
|
||||||||
|---|---|---|---|---|---|---|---|---|
| Database | CutSeq | Mapped Position | Protease | Type | Evidence | PMID | ||
| PAPER | No_information | metalloproteinase nardilysin | 24848066    | |||||
|
|
|||
|---|---|---|---|
| Secretome Database | Cell Type or Body Fluid | PubMed Reference | |
| Sys-BodyFluid | Urine | 16948836 | |